Patent ID: 11884680
Assignee: CELGENE QUANTICEL RESEARCH, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 1:
2. The method of claim 1, wherein the compound, or a pharmaceutically acceptable salt has the structure of Formula (Ib),, wherein:
R2 is selected from CH3;
X5 is C—H;
X6 is C—R6;
X7 is C—R7;
X8 is C—H;
R6 is hydrogen, or halogen;
R7 is hydrogen, or halogen;
RA is, X2 is C—H;
R13 is —Y—Z;
Y is selected from a bond, or —CH2—;
Z is selected from —SO2R21, —N(R22)SO2R21, —SO2N(R22)2, —N(R22)SO2N(R22)2, —CON(R22)2, —N(R22)CO2R21, —N(R22)CON(R22)2, —N(R22)COR21, —OC(O)N(R22)2, —OSO2N(R22)2, or —N(R22)SO3R21;
X3 is C—R14, wherein R14 is hydrogen, halogen, C1-C3 alkyl, or C1-C3 alkoxy;
X4 is C—R15, wherein R15 is hydrogen, or halogen;
R16 is —W—X, wherein W is a bond, —O—, —S—, or —NH—, and X is selected from alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, or heteroarylalkyl;
each R21 is independently selected from alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, or heteroarylalkyl; and
each R22 is independently selected from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, or heteroarylalkyl.